Medtech product and innovation leader who builds production AI.
Founding R&D head on a robotic surgical device, from concept to FDA De Novo and first-in-human. Now building AI systems — agents, data platforms and guardrailed tools.
2021
FDA De Novo authorization
2023
First-in-human trial, published
Over$3.6M
SBIR funding as PI
100+
startup proposals scored for NIH
5
US patents
21
peer-reviewed papers
2
production MCP servers, and AI recommendations a person approves and re-checks 14 days later
From early 2027, I'm looking for a full-time role at a medtech, diagnostics or health-tech company. I want to get back to building new things in healthcare, and to bring the AI systems I've been building since mid-2025 into regulated work.
What I bring
Where the two meet: design controls applied to AI. That means approval gates, audit trails, guards in code, and verification before release.
109
tables in one Postgres database, fed by 30 scheduled jobs
Grew the storefront into one Next.js app that runs the whole business, on one Postgres database with 30 scheduled jobs. Four Claude Code analyst agents recommend what to do next; a person approves anything that changes.
Founding employee and R&D head on a robotic system for cochlear-implant surgery, from company start to FDA De Novo authorization in 2021 and a first-in-human trial. PI on four SBIR awards, over $3.6M.
2
client case studies: clinical-development outreach and a proposal builder
Robots & Bacon is my part-time consulting practice. I help owner-run service businesses answer their customers faster with AI. Client work includes custom outreach for clinical development and a proposal builder whose AI can't make up a price.
iotaMotion era · 7
Rice era · 14
9 granted worldwide, in the US, Europe, China and Australia.
Outside work I read a lot, swim and do woodworking. Father of three.
